Correlation Between Eliem Therapeutics and Lumos Pharma
Can any of the company-specific risk be diversified away by investing in both Eliem Therapeutics and Lumos Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Eliem Therapeutics and Lumos Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Eliem Therapeutics and Lumos Pharma, you can compare the effects of market volatilities on Eliem Therapeutics and Lumos Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Eliem Therapeutics with a short position of Lumos Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Eliem Therapeutics and Lumos Pharma.
Diversification Opportunities for Eliem Therapeutics and Lumos Pharma
-0.68 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Eliem and Lumos is -0.68. Overlapping area represents the amount of risk that can be diversified away by holding Eliem Therapeutics and Lumos Pharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Lumos Pharma and Eliem Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Eliem Therapeutics are associated (or correlated) with Lumos Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Lumos Pharma has no effect on the direction of Eliem Therapeutics i.e., Eliem Therapeutics and Lumos Pharma go up and down completely randomly.
Pair Corralation between Eliem Therapeutics and Lumos Pharma
Given the investment horizon of 90 days Eliem Therapeutics is expected to under-perform the Lumos Pharma. In addition to that, Eliem Therapeutics is 4.97 times more volatile than Lumos Pharma. It trades about -0.29 of its total potential returns per unit of risk. Lumos Pharma is currently generating about -0.16 per unit of volatility. If you would invest 445.00 in Lumos Pharma on August 28, 2024 and sell it today you would lose (15.00) from holding Lumos Pharma or give up 3.37% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Weak |
| Accuracy | 95.24% |
| Values | Daily Returns |
Eliem Therapeutics vs. Lumos Pharma
Performance |
| Timeline |
| Eliem Therapeutics |
| Lumos Pharma |
Eliem Therapeutics and Lumos Pharma Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Eliem Therapeutics and Lumos Pharma
The main advantage of trading using opposite Eliem Therapeutics and Lumos Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Eliem Therapeutics position performs unexpectedly, Lumos Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Lumos Pharma will offset losses from the drop in Lumos Pharma's long position.| Eliem Therapeutics vs. Pmv Pharmaceuticals | Eliem Therapeutics vs. MediciNova | Eliem Therapeutics vs. Pharvaris BV | Eliem Therapeutics vs. PepGen |
| Lumos Pharma vs. Shattuck Labs | Lumos Pharma vs. Eliem Therapeutics | Lumos Pharma vs. Champions Oncology | Lumos Pharma vs. Century Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Transformation module to use Price Transformation models to analyze the depth of different equity instruments across global markets.
Other Complementary Tools
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio |